"We'll be once again taking share," said Pyott, something that will help Botox continue to grow in the double digits. Among some of the new indications for the company is the use of Botox for migraines. Pyott said the migraine business is picking up steam and the company has trained over 6,000 doctors in its use so far. He said Allergan is running both branded and non-branded advertising in the migraine space, both of which are working well to find patients in need. Even newer to the company's stable of products are those for overactive bladder. Pyott said right now Allergan's treatments are approved for use with patients who have incontinence as a result of a spinal cord injury. In 2013 the company hopes to receive approval for severe incontinence, a far bigger indication than spinal injuries. Pyott also discounted a slowdown in the company's eye-care business, calling the anomaly a "blip" related primarily to inventory. Cramer continued his recommendation of Allergan.
No Huddle Offense
In his "No Huddle Offense" segment, Cramer explained exactly what caused shares of Chipotle Mexican Grill ( CMG) to pop more than $24 on seemingly no news. He said that Chipotle didn't report better same-store sales, nor provide an update on its new restaurant concept or signal a return to growth. Instead, what caused Chipotle to rally was yoga. Cramer said that when Lululemon Athletica ( LULU) reported a terrific number today, on the heels of beauty retailer Ulta Salon ( ULTA) doing the same, that was enough to set the growth investors into motion, taking up all of the once high-flying momentum names. Cramer said that yes, good news for yoga can cause a Mexican food chain to rally. The key, he said, is to be able to recognize that Lulu did indeed have good things to say. Once you recognize that, you can easily anticipate the moves of all the others. --Written by Scott Rutt in Washington, D.C. To email Scott about this article, click here: Scott Rutt Follow Scott on Twitter @ScottRutt or get updates on Facebook, ScottRuttDCTo watch replays of Cramer's video segments, visit the Mad Money page on CNBC.